Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol. Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse. Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase. Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, plasma corticosterone levels in Crhr1 KO mice were significantly less than those of WT mice after forced-swim stress (15).”
From Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation (2000) · cites this paper as [15]
In the citing paper
“CRF 1 overexpression results in an anxiogenic-and depressive-like profile in rodents and humans [342][343][344][345][346].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [343]
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Chalmers, D., Lovenberg, T., & De Souza, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 919
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Swanson, L. W., & Simmons, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850402 · Cited by 478
Stenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., & Vale, W. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468
Cited by
Items 101–200 of 1,000
Invited review: the evolution of antidepressant mechanisms
Slattery, D. A., Hudson, A. L., & Nutt, D. J. (2004) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00195.x · Cited by 186
Genetics of Affective and Anxiety Disorders
Leonardo, E. D., & Hen, R. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190118 · Cited by 184
Bland, M. L., Jamieson, C. A. M., Akana, S. F., Bornstein, S. R., Eisenhofer, G., Dallman, M. F., & Ingraham, H. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14488 · Cited by 183
The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response
Dedic, N., Chen, A., & Deussing, J. M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170302104053 · Cited by 182
Newport, D. J., Heim, C., Bonsall, R., Miller, A. H., & Nemeroff, C. B. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00692-9 · Cited by 182
Bonfiglio, J. J., Inda, C., Refojo, D., Holsboer, F., Arzt, E., & Silberstein, S. (2011) · Neuroendocrinology · doi:10.1159/000328226 · Cited by 145
Self-citationArai, M., Assil, I. Q., & Abou-Samra, A. B. (2001) · Endocrinology · doi:10.1210/endo.142.1.7879 · Cited by 142
Martínez, V., Wang, L., Rivier, J., Grigoriadis, D., & Taché, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.059659 · Cited by 179
“Mice deficient in CRF ligands and receptors have proved to be valuable to gain insight into the CRF signalling pathways involved in the endocrine and behavioural responses to stress (Smith et al. 1998; Timpl et al. 1998; Bale et al. 2002).”
BackgroundOu, X.-M., Storring, J. M., Kushwaha, N., & Albert, P. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005363200 · Cited by 178
The therapeutic potential of CRF1 antagonists for anxiety
Zorrilla, E. P., & Koob, G. F. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.799 · Cited by 176
Maccarrone, M., Valverde, O., Barbaccia, M. L., Castañé, A., Maldonado, R., Ledent, C., Parmentier, M., & Finazzi‐Agrò, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01957.x · Cited by 151
“We used a box (Timpl et al., 1998) consisting of a small (15 cm wide 3 20 cm long 3 25 cm high) compartment with black walls and black ¯oor dimly lit (5 lux), connected by a 4-cm long tunnel to a large compartment (30 cm wide 3 20 cm long 3 25 cm high) with white walls and a white ¯oor, intensely…”
MethodTrends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
Pacher, P., & Kecskemeti, V. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455594 · Cited by 175
Transgenic Approach to the Study of Body Weight Regulation
Inui, A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01435-2 · Cited by 174
“…increase in the expression of CRF was detected within the PVN of the hypothalamus, but no detectable alteration was observed in the expression of CRF-2 receptor, CRF-binding protein, arginine vasopressin, or mineralocorticoid and glucocorticoid receptors (Smith et al., 1998; Timpl et al., 1998).”
BackgroundNociception, pain, and antinociception: current concepts
Riedel, W., & Neeck, G. (2001) · Zeitschrift f�r Rheumatologie · doi:10.1007/s003930170003 · Cited by 173
Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior
Vetter, D. E., Li, C., Zhao, L., Contarino, A., Liberman, M. C., Smith, G. W., Marchuk, Y., Koob, G. F., Heinemann, S. F., Vale, W., et al. (2002) · Nature Genetics · doi:10.1038/ng914 · Cited by 173
Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression
Pfennig, A., Kunzel, H. E., Kern, N., Ising, M., Majer, M., Fuchs, B., Ernst, G., Holsboer, F., & Binder, E. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.017 · Cited by 172
Self-citationBakshi, V. P., Smith-Roe, S., Newman, S. M., Grigoriadis, D. E., & Kalin, N. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02926.2002 · Cited by 171
“Moreover, the present findings suggest that decreases in stress-induced behaviors after CRH1 receptor knock-out or systemic CRH1 receptor antagonist administration may involve the CeA (Smith et al., 1998; Timpl et al., 1998; Contarino et al., 1999; Okuyama et al., 1999; Habib et al., 2000).”
BackgroundInnovative Approaches for the Treatment of Depression: Targeting the HPA Axis
THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 171
“A decrease in CRF1 expression, either through anti-sense knock-down in rat amygdala [71] or via generation of germ-line knock-out mice [72, 73] is associated with reduced anxiety behaviour.”
BackgroundChu, K., Koob, G. F., Cole, M., Zorrilla, E. P., & Roberts, A. J. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.03.009 · Cited by 170
“CRF1 knockout mice display decreased anxiety-like behavior (Smith et al., 1998; Contarino et al., 1999; Timpl et al., 1998) and may be less sensitive to the anxiogeniclike effects of ethanol withdrawal (Timpl et al., 1998).”
BackgroundHarro, J., & Oreland, L. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00082-0 · Cited by 170
Neuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
Molecular targets in the treatment of anxiety
Kent, J. M., Mathew, S. J., & Gorman, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01672-4 · Cited by 167
Genetic animal models of anxiety
Finn, D. A., Rutledge-Gorman, M. T., & Crabbe, J. C. (2003) · Neurogenetics · doi:10.1007/s10048-003-0143-2 · Cited by 166
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats
Keck, M. E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F., & Landgraf, R. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01383.x · Cited by 154
“…Holsboer, 1999; Keck & Holsboer, 2000) can be attributed to an enhanced activity of CRH secreting neurons which act through CRHR1 (Britton et al., 1982; Sutton et al., 1982; Liebsch et al., 1995, 1999; Heinrichs et al., 1997a,b; Skutella et al., 1998; Smith et al., 1998; Timpl et al., 1998).”
BackgroundSelf-citationThe role of CRH in behavioral responses to stress
Smagin, G. N., Heinrichs, S. C., & Dunn, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00384-9 · Cited by 166
Wittmann, W., Schunk, E., Rosskothen, I., Gaburro, S., Singewald, N., Herzog, H., & Schwarzer, C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.142 · Cited by 165
“…injection of CRH or overexpression of CRH is anxiogenic in mice (Stenzel-Poore et al, 1996) and inactivation of CRH receptor 1 reduces anxiety (Smith et al, 1998; Timpl et al, 1998), whereas deletion of CRH receptor 2 is anxiogenic (Bale et al, 2000; Coste et al, 2000; Kishimoto et al, 2000).”
Stasi, C., Rosselli, M., Bellini, M., Laffi, G., & Milani, S. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0627-7 · Cited by 164
“Inhibition by CRH antagonists [28] or experimental inactivation of CRH receptor 1 result in a decreased response to stress [29, 30], suggesting that hypersecretion of CRH in the brain may contribute to the pathophysiology of stress-related exacerbation of IBS [27].”
BackgroundStress and alcohol interactions: animal studies and clinical significance
Spanagel, R., Noori, H. R., & Heilig, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.006 · Cited by 163
Self-citationTreatment-resistant depression: are animal models of depression fit for purpose?
Willner, P., & Belzung, C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4034-7 · Cited by 163
“…van Gaalen et al. 2002), mice with CRH overexpression in neurons (Dirks et al. 2001; Groenink et al. 2002), CRFR1 knockout mice (Smith et al. 1998; Timpl et al. 1998), mice with transient perinatal forebrain CRF overexpression (Kolber et al. 2010), mice with conditional forebrain-restricted…”
BackgroundAltered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice
Karolyi, I. J., Burrows, H. L., Ramesh, T., Nakajima, M., Lesh, J., Seong, E., Camper, S. A., & Seasholtz, A. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11595 · Cited by 163
Corticotropin releasing hormone receptors: two decades later
Aguilera, G., Nikodemova, M., Wynn, P. C., & Catt, K. J. (2004) · Peptides · doi:10.1016/j.peptides.2004.02.002 · Cited by 162
Role of Corticotropin-Releasing Factor (CRF) Receptors in the Anorexic Syndrome Induced by CRF
Pelleymounter, M. A., Joppa, M., Carmouche, M., Cullen, M. J., Brown, B., Murphy, B., Grigoriadis, D. E., Ling, N., & Foster, A. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39300-0 · Cited by 150
“Furthermore, the CRF1 knockout mouse shows reduced anxiety and an impaired stress response (Smith et al., 1998; Timpl et al., 1998).”
Pompili, M., Serafini, G., Innamorati, M., Möller-Leimkühler, A. M., Giupponi, G., Girardi, P., Tatarelli, R., & Lester, D. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0108-z · Cited by 161
“In contrast, the deletion of the highly homologous crhr1 receptor results in a decreased anxiety in stressed animals [230, 244].”
BackgroundOhl, F. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-28082-0_2 · Cited by 160
GENETIC APPROACHES TO THE STUDY OF ANXIETY
Gordon, J. A., & Hen, R. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144212 · Cited by 141
“Unlike the original CRH-R1 knockout, which has a dramatically reduced HPA axis response to stress, the tissue-specific knockout has slightly increased ACTH and corticosterone responses to stress (Müller et al. 2003, Timpl et al. 1998).”
BackgroundThe anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1
Sztainberg, Y., Kuperman, Y., Tsoory, M., Lebow, M., & Chen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.151 · Cited by 159
Zorrilla, E. P., Valdez, G. R., Nozulak, J., Koob, G. F., & Markou, A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03189-x · Cited by 159
Valdez, G. R., Inoue, K., Koob, G. F., Rivier, J., Vale, W., & Zorrilla, E. P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02707-5 · Cited by 158
Generation of neuropeptidergic hypothalamic neurons from human pluripotent stem cells
Merkle, F. T., Maroof, A., Wataya, T., Sasai, Y., Studer, L., Eggan, K., & Schier, A. F. (2015) · Development · doi:10.1242/dev.117978 · Cited by 152
Valdez, G. R., & Koob, G. F. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.020 · Cited by 157
Lolait, S. J., Stewart, L. Q., Jessop, D. S., Young, W. S., & O’Carroll, A.-M. (2007) · Endocrinology · doi:10.1210/en.2006-1309 · Cited by 146
Lu, A., Steiner, M. A., Whittle, N., Vogl, A. M., Walser, S. M., Ableitner, M., Refojo, D., Ekker, M., Rubenstein, J. L. R., Stalla, G. K., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.51 · Cited by 156
Self-citationCorticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation
Rissman, R. A., Lee, K., Vale, W., & Sawchenko, P. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5173-06.2007 · Cited by 156
“CRFR1-deficient mice exhibit impaired hormonal and behavioral responses to stress, whereas CRFR2 knock-outs are hyperresponsive on many of the same measures (Smith et al., 1998; Timpl et al., 1998; Bale et al., 2000; Coste et al., 2000; Kishimoto et al., 2000).”
Heinrichs, S. C., Souza, E. B. D., Schulteis, G., Lapsansky, J. L., & Grigoriadis, D. E. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00299-3 · Cited by 155
Sauvage, M. M., & Steckler, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00137-3 · Cited by 154
Self-citationGarcía-Gutiérrez, M. S., & Manzanares, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379507 · Cited by 153
“Dysfunctions of the HPA axis have been associated with stress- and anxiety-related behaviours in rodents (Arborelius et al., 1999; Dunn and Berridge, 1990; Smith et al., 1998; Stenzel-Poore et al., 1994; Timpl et al., 1998) and anxiety disorders in humans (Altemus et al.”
BackgroundPharmacotherapy of PTSD: premises, principles, and priorities.
Ravindran, L. N., & Stein, M. B. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.037 · Cited by 153
“The CRH1 receptor in particular has been implicated in CRH mediation of stress-response behaviors with studies of CRH1 knockout rodents demonstrating a reduction in anxiety-related behavior (Hauger et al., 2006; Timpl et al., 1998).”
BackgroundValdez, G. R., Zorrilla, E. P., Rivier, J., Vale, W., & Koob, G. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02971-8 · Cited by 153
Tracing the dynamics of gene transcripts after organismal death
Pozhitkov, A. E., Neme, R., Domazet-Lošo, T., Leroux, B. G., Soni, S., Tautz, D., & Noble, P. A. (2017) · Open Biology · doi:10.1098/rsob.160267 · Cited by 144
HPA Axis Interactions with Behavioral Systems
Packard, A. E. B., Egan, A. E., & Ulrich‐Lai, Y. M. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150042 · Cited by 149
Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response
Baigent, S. (2001) · Peptides · doi:10.1016/s0196-9781(01)00395-3 · Cited by 146
Grammatopoulos, D. K., Dai, Y., Randeva, H., Levine, M. A., Karteris, E., Easton, A. J., & Hillhouse, E. W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2189 · Cited by 124
Mutant mouse models of depression: Candidate genes and current mouse lines
Urani, A., Chourbaji, S., & Gass, P. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.020 · Cited by 144
Hammack, S. E., Roman, C. W., Lezak, K. R., Kocho-Shellenberg, M., Grimmig, B., Falls, W. A., Braas, K., & May, V. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9364-7 · Cited by 127
“Extrahypothalamic CRH has been heavily implicated in mediating many of the behavioral responses to stressful stimuli, including fear and anxiety (Koob and Heinrichs 1999), and CRH1 receptor knockout mice exhibit an anxiolytic behavioral profile (Timpl et al. 1998).”
Pedersen, W. A., Wan, R., Zhang, P., & Mattson, M. P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00404.2002 · Cited by 135
“Studies with CRHR1 antagonists (Webster et al., 1996; Habib et al., 2000) and of mice lacking the CRHR1 gene (Smith et al., 1998; Timpl et al., 1998) suggest that this receptor is critical for activation of the hypothalamic–pituitary–adrenal (HPA) axis and stress responses.”
BackgroundHodge, C. W., Raber, J., McMahon, T., Walter, H., Sanchez-Perez, A. M., Olive, M. F., Mehmert, K., Morrow, A. L., & Messing, R. O. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215903 · Cited by 136
“Moreover, several single gene mutations alter anxiety-like behavior in mice, including null mutations in the corticotropin-releasing factor (CRF) receptor-1 (7, 8), the glucocorticoid receptor (9), the α subunit of calcium/calmodulin–dependent protein kinase II (10), and protein kinase Cγ (PKCγ) (11), which all reduce…”
O’Keane, V., Frodl, T., & Dinan, T. G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.009 · Cited by 140
Bruijnzeel, A. W., & Gold, M. S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.007 · Cited by 140
Corticotropin-releasing hormone and animal models of anxiety: gene–environment interactions
Bakshi, V. P., & Kalin, N. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01082-9 · Cited by 139
“P. Bakshi and N.H. Kalin reduced level of anxiety in CRH 1 knockout mice (Contarino et al 1999a; Smith et al 1998; Timpl et al 1998 ).”
Dissection of behavior and psychiatric disorders using the mouse as a model
Tarantino, L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.953 · Cited by 129
Preil, J. (2001) · Endocrinology · doi:10.1210/en.142.11.4946 · Cited by 122
Self-citationBhutada, P., Mundhada, Y. R., Bansod, K. U., Ubgade, A., Quazi, M., Umathe, S. N., & Mundhada, D. R. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.025 · Cited by 136
“The hypothalamic–pituitary–adrenal (HPA) axis is a major component of the stress response and is vital for survival, whereas its abnormal activation by stressful conditions is an important risk factor for anxiety and depression (Smith et al., 1998; Timpl et al., 1998; Kawabata et al., 2010).”
Gass, P., Reichardt, H. M., Strekalova, T. V., Henn, F. A., & Tronche, F. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00518-2 · Cited by 136
Sensitivity to stress: Dysregulation of CRF pathways and disease development
Bale, T. L. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.01.009 · Cited by 134
Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression
Held, K., Kunzel, H. E., Ising, M., Schmid, D. A., Zobel, A. W., Murck, H., Holsboer, F., & Steiger, A. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00076-1 · Cited by 134
“…use of antisense probes directed against CRH1 receptor mRNA and mouse mutants with CRH1 receptor deficiency (Liebsch et al., 1999; Smith, 1998; Timpl et al., 1998) all agree that CRH1 receptors mediate CRH elicited depressive symptoms a selective CRH1 receptor antagonist, R121919 was…”
BackgroundSelf-citationEvaluation of an Anxiety-Related Phenotype in Galanin Overexpressing Transgenic Mice
Holmes, A., Yang, R. J., & Crawley, J. N. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:151 · Cited by 134
“…(Stenzel-Poore et al., 1996) and CRF-R2 receptor knockout mice (Bale et al., 2000; 2002; Kishimoto et al., 2000) show heightened anxiety-like behavior, whereas deletion of the CRF-R1 receptor or CRF itself leads to reduced anxiety-like behavior in mice (Smith et al., 1998; Timpl et al., 1998).”
BackgroundBrain mechanisms underlying emotional alterations in the peripartum period in rats
Neumann, I. D. (2003) · Depression and Anxiety · doi:10.1002/da.10070 · Cited by 121
Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety
Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450
Chaki, S., Nakazato, A., Kennis, L. E. J., Nakamura, M., Mackie, C. E., Sugiura, M., Vinken, P., ASHTON, D. S., Langlois, X., & Steckler, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.032 · Cited by 132
Self-citationValdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Molecular biology of the CRH receptors— in the mood
Dautzenberg, F. M., Kilpatrick, G. J., Hauger, R. L., & Moreau, J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00388-6 · Cited by 131
The Dynamics of the Hypothalamic‐Pituitary‐Adrenal Axis During Maternal Deprivation
Schmidt, M., Enthoven, L., Van Woezik, J. H. G., Levine, S., De Kloet, E. R., & Oitzl, M. S. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01123.x · Cited by 111
Neumann, I. D., Krömer, S. A., & Bosch, O. J. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.03.008 · Cited by 127
Ohl, F. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00084-7 · Cited by 127
Skelton, K. H., Nemeroff, C. B., Knight, D. L., & Owens, M. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01240.2000 · Cited by 119
“The recent demonstration that CRF1 receptor knock-out mice exhibit decreased basal and stress-induced anxiety further supports a role for CRF in the mediation of anxiogenic behaviors (Timpl et al., 1998).”
BackgroundLoss of hypothalamic corticotropin-releasing hormone markedly reduces anxiety behaviors in mice
Zhang, R., Asai, M., Mahoney, C. E., Joachim, M., Shen, Y., Gunner, G., & Majzoub, J. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.136 · Cited by 97
Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress
Coste, S. C., Murray, S., & Stenzel‐Poore, M. P. (2001) · Peptides · doi:10.1016/s0196-9781(01)00386-2 · Cited by 126
Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala
Bajo, M., Cruz, M. T., Siggins, G. R., Messing, R., & Roberto, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802302105 · Cited by 119
Venihaki, M., Sakihara, S., Subramanian, S., Dikkes, P., Weninger, S. C., Liapakis, G., Graf, T., & Majzoub, J. A. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01170.x · Cited by 115
Bangasser, D. A. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-2 · Cited by 107
Kamprath, K., Plendl, W., Marsicano, G., Deussing, J. M., Wurst, W., Lutz, B., & Wotjak, C. T. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00463.x · Cited by 105
“…different phenotypes in anxiety-related behavior when compared with their respective wild-type littermates, with CRHR1 / showing decreased anxiety (Timpl et al. 1998) and different lines of CRHR2deficient mice showing either increased anxiety (Bale et al. 2000; Kishimoto et al. 2000) or no…”
BackgroundMethodResultSelf-citationHiroi, N., Wong, M. L., Licinio, J., Park, C., Young, M., Gold, P. W., Chrousos, G. P., & Bornstein, S. R. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000908 · Cited by 124
Wang, X., Labermaier, C., Holsboer, F., Wurst, W., Deussing, J. M., Müller, M. B., & Schmidt, M. V. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08148.x · Cited by 107
Self-citationHotta, M., Shibasaki, T., Arai, K., & Demura, H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01177-4 · Cited by 123
Gehlert, D. R., Shekhar, A., Morin, S. M., Hipskind, P. A., Zink, C., Gackenheimer, S. L., Shaw, J., Fitz, S. D., & Sajdyk, T. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.030 · Cited by 123
Abnormal fluid homeostasis in apelin receptor knockout mice
Roberts, E., Newson, M. J. F., Pope, G. R., Landgraf, R., Lolait, S. J., & O’Carroll, A. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0134 · Cited by 123
“Partial lethality has been previously observed in KO mouse models of other GPCRs expressed in the hypothalamus and/or pituitary, such as the corticosterone releasing hormone receptor 1 (Smith et al. 1998, Timpl et al. 1998).”
BackgroundDoes the vagus nerve mediate the sixth sense?
Zagon, A. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01929-9 · Cited by 121
Gaszner, B., Csernus, V., & Kozicz, T. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20343 · Cited by 106
“…CRF-R2 display anxietylike behaviors and hypersensitivity to stress (Bale et al., 2000; Bale et al., 2002), whereas studies on CRF-R1 knockouts, reported to date, reveal central function for CRF-R1 in mediating anxiety and neuroendocrine stress responses (Smith et al., 1998; Timpl et al., 1998).”
BackgroundCorticosteroid receptors in the brain: gene targeting studies
Kellendonk, C., Gass, P., Kretz, O., Schütz, G., & Tronche, F. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00638-4 · Cited by 121
Jacob, W., Yassouridis, A., Marsicano, G., Monory, K., Lutz, B., & Wotjak, C. T. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00512.x · Cited by 94
“Setup and test procedure were essentially the same as described before (Muller et al. 2003; Timpl et al. 1998).”
MethodContarino, A., & Papaleo, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506999102 · Cited by 107
Endocrine disturbances in depression
Tichomirowa, M. A., Keck, M. E., Schneider, H. J., Páez-Pereda, M., Renner, U., Holsboer, F., & Stalla, G. K. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345535 · Cited by 118
Self-citationThe Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00244.x · Cited by 112
Zohar, I., & Weinstock, M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02117.x · Cited by 109
Impact of aging on stress-responsive neuroendocrine systems
Pedersen, W. A., Wan, R., & Mattson, M. P. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00250-0 · Cited by 117
Pedersen, W. A., McCullers, D., Culmsee, C., Haughey, N. J., Herman, J. P., & Mattson, M. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0395 · Cited by 109
He, L., Gilligan, P. J., Zaczek, R. C., Fitzgerald, L. W., McElroy, J., Shen, H.-S. L., Saye, J. A., Kalin, N. H., Shelton, S. E., Christ, D. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9904351 · Cited by 117
Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas
Refojo, D., Echenique, C., Müller, M. B., Reul, J. M. H. M., Deussing, J. M., Wurst, W., Sillaber, I., Paez-Pereda, M., Holsboer, F., & Arzt, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502070102 · Cited by 104
Self-citationRoman, C. W., Lezak, K. R., Hartsock, M. J., Falls, W. A., Braas, K. M., Howard, A. B., Hammack, S. E., & May, V. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.05.014 · Cited by 115
“…consistent with their roles in stress-related activities, PACAP and PAC1 receptor knockout mice display diminished anxiety-related phenotypes (Timpl et al., 1998; Hashimoto et al., 2001; Otto et al., 2001; Hattori et al., 2012) and impaired stress-induced HPA responses (Stroth and Eiden,…”
BackgroundMüller, M. B., Landgraf, R., Preil, J., Sillaber, I., Kresse, A. E., Keck, M. E., Zimmermann, S., Holsboer, F., & Wurst, W. (2000) · Endocrinology · doi:10.1210/endo.141.11.7767 · Cited by 99
Self-citation
Metadata
- Authors
- Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Helmholtz Munich (DE)
- Corresponding author
- Wurst, Wolfgang
- Venue
- Nature Genetics
- Published
- 1998-06
- Volume
- 19
- Issue
- 2
- Pages
- 162-166
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/520
- OpenAlex
- W1572525448
- Semantic Scholar
- 963e2500bc129b9bfedf1ae198ec17a73626fcdc
- Cited by
- 919
- References
- 32
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 16 · 2020: 9 · 2019: 20 · 2018: 23 · 2017: 20 · 2016: 27 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 47
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Site cant be reached (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- corticotropin-releasing hormone receptor 1, stress response, anxiety-like behavior, ACTH, corticosterone, alcohol withdrawal, exploratory activity, CRH receptor 2, adenylate cyclase
- MeSH terms
- CRF Receptor, Type 1, Adrenocorticotropic Hormone, Ethanol, Animals, Anxiety, Cells, Cultured, Corticosterone, Pituitary Gland, Stress, Physiological, Substance Withdrawal Syndrome, In Situ Hybridization, Receptors, Corticotropin-Releasing Hormone, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.